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High Tuberculosis 
and HIV Coinfection 
Rate, Johannesburg
To the Editor: Tuberculosis (TB) 
is the leading cause of illness and 
death among HIV-1–infected patients 
in sub-Saharan Africa (1–3), but valid 
data on the population-level interac-
tion between the TB and HIV epidem-
ics are scarce (4). Our objective was 
to determine the extent of this dual 
epidemic in our setting, a hospital in 
Johannesburg, South Africa. We did 
this by introducing bedside TB and 
HIV counseling. We also intended to 
increase the use of voluntary counsel-
ing and testing for our TB patients and 
facilitate referral to our antiretroviral 
clinic.
From February to April 2006, 2 
volunteers from Community AIDS 
Response (CARE) counseled patients 
admitted to the medical wards of the 
Helen Joseph Hospital. This regional 
hospital serves a catchment population 
of >500,000 people, predominantly 
low-income black Africans. Coun-
selors provided TB and HIV well-
ness and adherence information, HIV 
pretest counseling, and referral to the 
Themba Lethu Clinic for rapid testing 
that used standard CARE modules.
Basic demographic, TB, and HIV 
data from patient records were docu-
mented on standard data collection 
forms. Missing data were extracted 
from the hospital database and Ther-
apy Edge-HIV, the data management 
system used by the HIV clinic. HIV 
testing was conducted with a fourth-
generation ELISA or rapid ﬁ  nger prick 
antibody test, according to World 
Health Organization guidelines.
Most admissions were for pulmo-
nary TB. A total of 467 patients receiv-
ing TB treatment were counseled; 8 of 
these patients refused the TB counsel-
ing service, and 2 refused voluntary 
counseling and testing for HIV. These 
467 patients constituted 13% of medi-
cal admissions and excluded the 1,075 
patients seen at the hospital’s outpa-
tient clinic with suspected TB for this 
3-month period. Our impression is 
that this ﬁ  gure constitutes an under-
representation of the total TB admis-
sions because TB counselors were not 
able to see every patient with TB.
Laboratory data were retrievable 
for 373 inpatients. For 301 (81%) of 
the 373 patients, TB blood culture, 
smear, or culture results could be 
traced. Hence, 72 (19%) of 373 pa-
tients who were receiving TB treatment 
had no record of a diagnostic effort to 
conﬁ  rm TB. A total of 284 (76%) HIV 
test results could be traced; 270 (95%) 
of the 284 accessible TB patients had 
concurrent HIV infection (Table).
Most (123 [89%]) documented 
HIV results were from ELISAs per-
formed during admission. Rapid 
testing performed in the ward was 
unacceptable to patients because con-
ﬁ  dentiality was compromised in large, 
busy wards and patients were often too 
ill to move to a side room. The system 
of making an appointment with the 
HIV clinic at the time of discharge 
failed because few patients (5%) actu-
ally had the rapid test after admission 
or began antiretroviral therapy. Those 
who began such therapy would have 
been captured on our database.
The level of concurrent TB and 
HIV coinfection at the hospital was 
95%. To the best of our knowledge, 
this is the highest level ever described 
in the peer-reviewed English-language 
literature (5). This ﬁ  nding may reﬂ  ect 
the selection bias for our inpatients, 
who generally would have more coex-
isting conditions than outpatients do. 
Also, HIV data were missing for 24% 
of the 373 patients, a fact that may 
also inﬂ  uence this ﬁ  nding. 
The peak age incidence of TB in 
our population corresponds with pre-
viously published data and is similar 
to the peak age incidence of the HIV 
epidemic in South Africa (6). In one 
third of the admitted patients, no TB 
investigations were undertaken. This 
may be because patients provided a 
history of TB diagnosed elsewhere, 
or it may reﬂ  ect the high rate of spu-
tum smear negativity in the HIV-in-
fected population, which lowers the 
clinician’s threshold for empiric TB 
treatment.
Mycobacteremia appeared to be 
less common (14%) than reported in 
other African studies (7). However, we 
did not have a complete dataset—only 
195 (52%) of the 373 patients could 
be evaluated.
TB and HIV have reached un-
precedented levels in our urban inpa-
tient population. TB and HIV must 
be viewed as different sides of the 
same coin, and services and staff must 
change accordingly. We need to use 
the opportunity of hospital admission 
to educate patients on the interaction 
between these 2 epidemics and facili-
tate patient referral for long-term man-
agement. Such management would 
include voluntary counseling and test-
ing, as well as antiretroviral medica-
tion. The latter is a recognized strategy 
of TB control because it reduces the 
risk for TB by 70%–90% (8). 
In addition, all inpatient proce-
dures in our TB/HIV control programs 
need to be strengthened. Infection 
control interventions to limit the high 
rates of nosocomial transmission of 
TB to other vulnerable patients and 
staff need to be instituted. At our hos-
pital, we are committed to these ap-
proaches. To this end, we have secured 
Table. Results of HIV testing by method of HIV diagnosis among accessible patients 
with tuberculosis, Johannesburg, South Africa 
Method
No. positive/ 
no. patients (%) 
No. negative/ 
no. patients (%) 
ELISA 110/123 (89)  13/123 (11) 
Rapid test  32/32 (100)  0/32 (0) 
Clinical diagnosis only  61/61 (100)  0/61 (0) 
HIV status known to patient  67/68 (99)  1/68 (1) 
Total 270/284 (95)  14/284 (5) LETTERS
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a Presidents Emergency Plan for AIDS 
Relief Grant via the nongovernmen-
tal organization Right to Care, which 
shares our vision. Urgent and extraor-
dinary measures are indeed required 
in our combined control programs to 
achieve the Millennium Development 
Goals for TB/HIV.
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Tuberculosis 
Trends, Vietnam 
To the Editor: The aims of the 
global strategy for tuberculosis (TB) 
control, the directly observed treat-
ment short-course (DOTS) strategy, 
of the World Health Organization 
(WHO) are to detect >70% of new 
smear-positive pulmonary TB cases 
and cure >85% of these detected cases 
(1). If these aims are met in a setting of 
low prevalence of multidrug-resistant 
TB and HIV infection, TB incidence 
is predicted to decrease by >7% an-
nually (2). Vietnam has a low preva-
lence of multidrug-resistant TB (2.3% 
in 1996–1997 [3]) and a low level of 
HIV infection in the adult population 
(0.4% in 2003, range 0.2%–0.8% [4]). 
It is the only country of 22 countries 
with the highest number of TB cases 
worldwide that has reached and ex-
ceeded WHO targets for TB control 
since 1997 (5,6). However, this coun-
try has not shown any decrease in TB 
reporting (5).
Reports may not reﬂ  ect TB inci-
dence if the proportion of cases de-
tected and treated by the National Tu-
berculosis Program (NTP) varies over 
time. This incidence can be captured 
by assessing diagnostic efforts. We as-
sessed whether TB case reporting rates 
in Vietnam are not decreasing because 
of increased diagnostic efforts in ur-
ban, rural, and remote (mountainous) 
settings. Characteristics of the NTP in 
Vietnam have been reported (6,7). The 
research board of the National Hospi-
tal for Tuberculosis and Respiratory 
Diseases in Hanoi provided scientiﬁ  c 
and ethical clearance for this study.
Reporting and laboratory register 
data were collected from 66 randomly 
selected districts; sampling was strati-
ﬁ  ed to include 20 urban, 30 rural, and 
20 remote districts. The NTP deﬁ  nes a 
suspected TB case-patient as a person 
with a cough for >3 weeks. A suspect-
ed case-patient was a person with a 
diagnostic sputum smear examination 
result for acid-fast bacilli by direct mi-
croscopy. A total of 20% of suspected 
case-patients were randomly selected 
and their data were used. Diagnostic 
effort was the number of suspect cases 
per 10,000 persons. A case-patient was 
a person with new smear-positive pul-
monary TB. The reporting rate was the 
number of cases per 100,000 persons. 
Population sizes were derived from 
the national population census of 1999 
and projected populations (8).
We calculated trends in reporting 
rates for 1997–2004 by age, sex, and 
setting (urban, rural, and remote) be-
fore and after adjustment for diagnos-
tic effort by using Poisson regression 
and expressed the average annual per-
centage change with 95% conﬁ  dence 
intervals. Observed trends were ad-
justed for variation in diagnostic effort 
over time by standardizing the number 
of notiﬁ  ed cases to the rate of suspect-
ed cases in 1997 for that particular set-
ting, age, and sex category.
Total number of cases and sus-
pected cases during 1997–2004 were 
28,470 and 138,130 in urban districts, 
20,328 and 157,296 in rural districts, 
and 6,879 and 62,227 in remote dis-
tricts, respectively. The overall report-
ing rate per 100,000 persons in 2000 
was 78 in urban districts, 64 in rural 
districts, and 42 in remote districts. The 
annual change in overall reporting rates 
was 0.0% in urban districts, 0.4% higher 
in rural districts, and 0.2% lower in re-
mote districts (Figure). Reporting rates 
decreased annually in elderly persons 